Jürgen Kraus

Ismael Galve-Roperh2
Christine Börner2
Anna Chiarlone2
Manuel Guzmán2
2Ismael Galve-Roperh
2Christine Börner
2Anna Chiarlone
2Manuel Guzmán
Learn More
Endocannabinoids act as neuromodulatory and neuroprotective cues by engaging type 1 cannabinoid receptors. These receptors are highly abundant in the basal ganglia and play a pivotal role in the control of motor behaviour. An early downregulation of type 1 cannabinoid receptors has been documented in the basal ganglia of patients with Huntington's disease(More)
To investigate the role of mu opioid receptors in the reinforcing effects of psychotropic drugs, the voluntary ethanol intake and ethanol- and cocaine-induced conditioned place preference in mu opioid receptor-deficient mice and their wild-type counterpartners was tested. Moreover, dopamine D1 and D2 receptor binding was measured. It was found that ethanol(More)
  • Anna Chiarlone, Christine Börner, Laura Martín-Gómez, Ada Jiménez-González, Adrián García-Concejo, María L García-Bermejo +10 others
  • 2016
Cannabinoid CB1 receptor, the molecular target of endocannabinoids and cannabis active components, is one of the most abundant metabotropic receptors in the brain. Cannabis is widely used for both recreational and medicinal purposes. Despite the ever-growing fundamental roles of microRNAs in the brain, the possible molecular connections between the CB1(More)
  • 1